Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7390808
Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
granted -
US 7390815
Pyrazole compounds useful as protein kinase inhibitors
granted -
US 7388017
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
granted -
US 7388074
Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof
granted -
US 7388002
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
granted -
US 7381825
Histone deacetylase inhibitors
granted -
US 7378403
Akt inhibitors, pharmaceutical compositions, and uses thereof
granted -
US 7378422
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted -
US 7378552
Monoamine re-uptake inhibitors and methods relating thereto
granted -
US 7374770
Topical composition for follicular delivery of an ornithine decarboxylase inhibitor
granted -
US 7375228
Histone deacetylase inhibitors
granted -
US 7375079
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins
granted -
US 7375074
Body weight gain inhibitor
granted -
US 7371372
Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection
granted -
US 7368452
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted -
US 7365072
Inhibitors of p38
granted -
US 7365092
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted -
US 7361665
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
granted -
US 7358258
Prodrugs of an ERK protein kinase inhibitor
granted -
US 7358273
Inhibitors of caspases
granted -
US 7358259
HCV inhibitors and methods of using them
granted -
US 7354928
Small molecule inhibitors targeted at Bcl-2
granted -
US 7354919
Isoxazole compositions useful as inhibitors of ERK
granted -
US 7354580
Method of administering and using VEGF inhibitors for the treatment of human cancer
granted